Cleared Traditional

PDE-NEO (K133719) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K133719 · Hamamatsu Photonics K.K. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
112d
Days
Class 2
Risk

K133719 is an FDA 510(k) clearance for the PDE-NEO. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Hamamatsu Photonics K.K. (Washington Dc, US). The FDA issued a Cleared decision on March 27, 2014 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hamamatsu Photonics K.K. devices

Submission Details

510(k) Number K133719 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2013
Decision Date March 27, 2014
Days to Decision 112 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 107d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 54
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K133719.
SPY Elite Intraoperative Perfusion Assessment System
K182907 · Novadaq Technologies Ulc. (Now A Part of Stryker) · Jan 2019
GLOW800
K181537 · Leica Microsystems (Schweiz) AG · Sep 2018
CAAS Workstation
K180019 · Pie Medical Imaging BV · May 2018
GE INNOVA SOLID STATE XRAY IMAGER FLUROSOPIC X RAY SYSTEM
K113034 · Ge Healthcare · Dec 2011
INTEGRATED INNOVA - S5I SYSTEM OPTION
K111209 · Ge Healthcare · Jul 2011
ARTIS ZEE / ZEEGOS WITH SW VC14
K090745 · Siemens Medical Solutions USA, Inc. · Jun 2009